Raymond James Financial
ZURA icon

Raymond James Financial’s Zura Bio ZURA Stock Holding History

Raymond James Financial’s Portfolio ZURA Stock Details ZURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$170K Buy
28,820
+1,928
+7% +$9.18K ﹤0.01% 5080
2026
Q1 		$160K Buy
26,892
+383
+1% +$2.31K ﹤0.01% 4933
2025
Q4 		$139K Sell
26,509
-50,100
-65% -$198K ﹤0.01% 4866
2025
Q3 		$332K Sell
76,609
-37,582
-33% -$67.6K ﹤0.01% 4351
2025
Q2 		$120K Sell
114,191
-30,494
-21% -$36.5K ﹤0.01% 4780
2025
Q1 		$187K Sell
144,685
-3,815
-3% -$6.02K ﹤0.01% 4440
2024
Q4 		$371K Buy
+148,500
New +$529K ﹤0.01% 4070

Other funds holding ZURA

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Raymond James Financial's ZURA Position: Q2 2026 in Review

Raymond James Financial increased its Zura Bio (ZURA) stake by 7.2% in Q2 2026, buying an estimated $9.18K and bringing the position to 28,820 shares worth $170K. The position accounts for ﹤0.01% of the portfolio, ranked #5080.

Raymond James Financial first reported a position in ZURA in Q4 2024 and has held it in 7 quarters since. The position peaked at $371K in Q4 2024. 95 funds tracked by Wall St. Rank hold ZURA as of Q2 2026.

  • Raymond James Financial held 28,820 shares of Zura Bio worth $170K as of Q2 2026.
  • Raymond James Financial bought 1,928 Zura Bio shares in Q2 2026, an estimated $9.18K.
  • Zura Bio made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #5080 holding.
  • Raymond James Financial first reported a position in Zura Bio in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Zura Bio position peaked at $371K in Q4 2024.
  • 95 funds tracked by Wall St. Rank held Zura Bio as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.